Page last updated: 2024-12-07
acranil
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
acranil: structure; fluorescent cpd for cytogenetic studies; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 101742 |
SCHEMBL ID | 11946676 |
MeSH ID | M0048936 |
Synonyms (23)
Synonym |
---|
1-[(6-chloro-2-methoxy-acridin-9-yl)amino]-3-(diethylamino)propan-2-ol |
2-propanol, 1-[(6-chloro-2-methoxy-9-acridinyl)amino]-3-(diethylamino)- |
acranil |
skf 16214-a2 |
chlorometacrine |
1-[(6-chloro-2-methoxyacridin-9-yl)amino]-3-(diethylamino)propan-2-ol |
522-20-3 |
SCHEMBL11946676 |
sn 186 |
z7b99z492d , |
1-((6-chloro-2-methoxyacridin-9-yl)amino)-3-(diethylamino)propan-2-ol |
unii-z7b99z492d |
einecs 208-324-6 |
2-methoxy-6-chlor-9-(3-diethylamino-2-hydroxypropylamino)acridin |
chlormetacrine [mi] |
2-propanol, 1-((6-chloro-2-methoxy-9-acridinyl)amino)-3-(diethylamino)- |
chlormetacrine |
1-(6-chloro-2-methoxy-9-acridylamino)-3-diethylamino-2-propanol |
1-[(6-chloro-2-methoxy-9-acridinyl)amino]-3-(diethylamino)-2-propanol |
1-[(6-chloro-2-methoxyacridin-9(10h)-ylidene)amino]-3-(diethylamino)propan-2-ol |
DTXSID00966576 |
Q27295111 |
Z2574937069 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (10)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 10 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 21.18
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.18) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |